InnovAge Holding Corp.

InnovAge Holding Corp.

INNVNYSE / NASDAQHealthcareSmall cap

$9.16+$0.25 (+2.8%)

Last close · Data as of Nov 20, 2026

Market cap
$977.3M
P/E
-32.2x
EV / EBITDA
-102.4x
Revenue
$853.7M
Net margin
-3.6%
ROCE
-4.5%

+85.1% over the last year

InnovAge Holding Corp. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+0.1%
3M
-14.6%
6M
+22.0%
1Y
+85.1%
5Y
+8.9%

52-week range

Day change +$0.25 (+2.8%) from $8.91 to $9.16 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in INNV, bought on each weekday since 2021.

News & filings

What InnovAge Holding filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 30.3 million US dollars in fiscal 2025.

Strengths (1)

  • Revenue grew 11.8% in fiscal 2025.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach.

Read moreShow less

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.

Sector
Healthcare
Shares outstanding
135.4M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$977.3M
P/E
-32.2x
P/B
4.2x
EV / EBITDA
-102.4x
EV / Sales
1.2x
P/S
1.1x
52-week high
$12.11
52-week low
$4.79

Profitability

Operating margin
-1.9%
Net margin
-3.6%
EBITDA margin
-1.2%
ROE
-12.9%
ROCE
-4.5%
ROIC
-7.7%
ROA
-5.8%
Asset turnover
1.62

Growth

Revenue
$853.7M
Revenue growth, 1Y
11.8%
Revenue CAGR, 3Y
6.9%
Net profit growth, 1Y
42.1%
Free cash flow
$26.6M

Solvency

Current ratio
1.07
Debt / Equity
0.43
Debt / Assets
0.19
CFO / Net profit
-1.08
Cash / Market cap
6.6%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$853.7M
Cost of revenue$700.1M
Gross profit$153.6M
Operating expenses$169.8M
Selling, general and administrative$150.3M
Operating income-$16.1M
Interest and other-$17.9M
Pretax income-$34.0M
Tax and other-$3.7M
Net income-$30.3M

Revenue and net profit

Revenue grew 11.8% in FY2025; net profit is the dashed line.

InnovAge Holding Corp. revenue and net profit by fiscal year
InnovAge Holding Corp. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$698.6M-$6.5M
FY2023$688.1M-$40.7M
FY2024$763.9M-$21.3M
FY2025$853.7M-$30.3M

Cash flows

FY2025: $32.9M from operations, $26.6M free after investment (dashed).

InnovAge Holding Corp. operating and free cash flow by fiscal year
InnovAge Holding Corp. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$27.3M-$10.9M
FY2023$20.2M-$3.1M
FY2024-$36.9M-$44.8M
FY2025$32.9M$26.6M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$853.7M+11.8%1Y
EBITDA
-$9.9M-958.3%1Y
Net profit
-$30.3M
Cash from operations
$32.9M
Free cash flow
$26.6M
Revenue CAGR, 3Y
6.9%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$853.7M-$9.9M-$30.3M$26.6M-12.9%+11.8%+42.1%

Monthly returns

Month-by-month returns of INNV across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$526.9M
Liabilities$263.9M
Equity$262.9M
Paid-in capital$343.4M
Retained earnings-$101.0M
Treasury stock$7.5M
Minority interest$27.9M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; INNV highlighted.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

EV / Sales, for the companies without earnings

  1. InnovAge Holding Corp. (this company)1.2x

Not shown (no positive earnings and no EV / Sales): Corvus Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
InnovAge Holding Corp.INNVthis company$977.3M-32.2x4.2x-12.9%-102.4x
QuidelOrtho CorporationQDEL$1.0B-0.9x0.5x-58.9%-7.7x
EyePoint, Inc.EYPT$1.0B-4.4x3.4x-75.8%-4.1x
Artivion, Inc.AORT$1.0B103.7x2.3x2.2%18.9x
Corvus Pharmaceuticals, Inc.CRVS$985.5M-64.5x16.1x-25.0%-22.9x
U.S. Physical Therapy, Inc.USPH$940.1M62.4x2.0x3.2%11.1x
Anteris Technologies Global Corp.AVR$939.4M—48.7x-238.4%—
Olema Pharmaceuticals, Inc.OLMA$932.9M-5.7x1.9x-33.9%-5.0x
Nutex Health Inc.NUTX$929.7M13.1x2.8x21.5%3.8x
Peer median—-0.9x2.5x-29.5%-4.1x

Year-to-date ROI

INNV since 1 January, against earlier years.

Historical volatility

INNV's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

InnovAge Holding Corp. operating margin by fiscal year
InnovAge Holding Corp. operating margin by fiscal year
DateOperating margin
FY2022-0.6%
FY2023-7.2%
FY2024-3.0%
FY2025-1.9%
LineFY2025
Cost of revenueCost Of Revenue$700.1M
Gross profitGross Profit$153.6M
Operating expensesOperating Expense$169.8M
Other operating expensesOther Operating Expenses—
Depreciation and amortisationDepreciation And Amortization In Income Statement$19.5M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$19.5M
Total expensesTotal Expenses$869.8M
Pretax incomePretax Income-$34.0M

Learn while you research

Academy chapters picked for InnovAge Holding Corp. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →